Combined inhibition of HER2 and VEGFR synergistically improves therapeutic efficacy via PI3K-AKT pathway in advanced ovarian cancer
Abstract Background Ovarian cancer (OC) is a prevalent malignancy in the female reproductive system, and developing effective targeted therapies for this disease remains challenging. The aim of this study was to use clinically-relevant OC models to evaluate the therapeutic effectiveness of RC48, an...
Збережено в:
| Автори: | , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
BMC
2024-02-01
|
| Серія: | Journal of Experimental & Clinical Cancer Research |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1186/s13046-024-02981-5 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|